All News
Filter News
Found 808,690 articles
-
Postoperative Mortality Higher in Veterans With Psych Disorders, Veterans Affairs Medical Center Study
10/19/2010
-
Why Are Men More Susceptible to Alcoholism? It May Be in Their Dopamine, Columbia University and Yale University Study
10/19/2010
-
American College of Gastroenterology: Abdominal Pain May Be Traced to Fructose, Mary Bridge Children's Hospital Study
10/19/2010
-
Hold the Lime with Corona, May Cause Skin Reaction, Doctor Finds at Archives of Dermatology
10/19/2010
-
Fries, Chips Linked to Breast Cancer - New Maastricht University Medical Center Study
10/19/2010
-
American Society for Bone and Mineral Research: Novel Drug Promising in Osteoporosis, University of Erlangen Study Reveals
10/19/2010
-
Scientists Suggest that Cancer is Purely Man-Made, University of Manchester Study
10/19/2010
-
Getinge Sees Demand Slowing, Shares Fall
10/19/2010
-
GlaxoSmithKline Forms Alliance with Fondazione Telethon and Fondazione San Raffaele to Work on Gene Therapy for Rare Diseases
10/19/2010
-
American Academy of Ophthalmology: Retinoid Drug May Slow Dry AMD Progression
10/19/2010
-
Transcept Pharmaceuticals, Inc. to Resubmit NDA Application Again With Sleep-Disorder Drug, Intermezzo
10/19/2010
-
Somaxon Pharmaceuticals, Inc. Announces Paragraph IV ANDA Filing for Silenor
10/19/2010
-
New Data on Odanacatib, Merck Sharp & Dohme's Investigational Cathepsin-K Inhibitor for Osteoporosis, Presented at Merck & Co., Inc. Annual Meeting
10/19/2010
-
Ipsen: OBI-1 Receives Orphan Drug Designation in Europe
10/19/2010
-
Cytheris SA Announces Initiation of ORVACS-Sponsored Phase II Clinical Study to Attack Viral Reservoir of HIV Patients
10/19/2010
-
Adolor Corporation Initiates Phase 2 OIC Study of ADL5945
10/19/2010
-
Endologix Inc. Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
10/19/2010
-
MannKind Corporation Announces Initiation of Phase 2 Trial of Cancer Vaccine for Advanced Melanoma
10/19/2010
-
Calistoga Pharmaceuticals Announces Initiation of Phase 2 Trial of Delta-Isoform-Selective PI3 Kinase Inhibitor CAL-101 in Combination with Rituximab for the Treatment of Previously Untreated Elderly Patients with Chronic Lymphocytic Leukemia
10/19/2010
-
Biotechnology Firm ImmuneWorks Begins National Clinical Trial for New Idiopathic Pulmonary Fibrosis (IPF) Treatment
10/19/2010